Show simple item record

dc.contributor.authorOudard, S
dc.contributor.authorBenhamouda, N
dc.contributor.authorEscudier, B
dc.contributor.authorRavel, P
dc.contributor.authorKothari, D
dc.contributor.authorMehmud, F
dc.contributor.authorLevionnois, E
dc.contributor.authorSevin, E
dc.contributor.authorNegrier, S
dc.contributor.authorBarthelemy, P
dc.contributor.authorBerdah, J
dc.contributor.authorRavaud, A
dc.contributor.authorSternberg, C
dc.contributor.authorBono, P
dc.contributor.authorPorta, C
dc.contributor.authorDe Giorgi, U
dc.contributor.authorParikh, O
dc.contributor.authorHawkins, Robert E
dc.contributor.authorHighley, M
dc.contributor.authorTartour, E
dc.contributor.authorDecker, T
dc.contributor.authorWilkie, J
dc.date.accessioned2016-01-06T10:46:06Zen
dc.date.available2016-01-06T10:46:06Zen
dc.date.issued2015en
dc.identifier.citationDecrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC). 2015, 51 S89-S90 Eur J Canceren
dc.identifier.urihttp://hdl.handle.net/10541/592957en
dc.language.isoenen
dc.titleDecrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentHopital Europeen Georges Pompidou, Oncology, Paris, Franceen
dc.identifier.journalEuropean Journal of Canceren


This item appears in the following Collection(s)

Show simple item record